Previous experiments demonstrating disproportionately higher HER2 expression in the BC cell line BT474 than in the CRC cell line DLD1 and NSCLC cell line A549 [30] might partially explain the entity-specific TUC responses in our experiments and are in line with recent in vitro studies [13, 50]. The gene discussed is ERBB2; the disease is breast cancer.